Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2431 AL 2445

Reboxetine in clinical practice: a review

Sepede G, Corbo M, Fiori F, Martinotti G.

Clin Ter. 2012 Jul;163(4):e255-62.

Novel NMDA receptor modulators: an update

Santangelo RM, Acker TM, Zimmerman SS, Katzman BM, Strong KL, Traynelis SF, Liotta DC.

Expert Opin Ther Pat. 2012 Nov;22(11):1337-52. doi: 10.1517/13543776.2012.728587. Epub 2012 Sep 26.

Continuous buccolingual masticatory dyskinesia in Parkinson's disease

Meyniel C, Derkinderen P, Giumelli B, Damier P.

BMJ Case Rep. 2012 Sep 25;2012:bcr0920080910. doi: 10.1136/bcr.09.2008.0910.

Evaluation of olfactory dysfunction in neurodegenerative diseases

Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, Marino S.

J Neurol Sci. 2012 Dec 15;323(1-2):16-24. doi: 10.1016/j.jns.2012.08.028. Epub 2012 Sep 23.

Implantation of a cardiac resynchronization therapy defibrillator in a patient with bilateral deep brain stimulator: feasibility and technique

Karimi A, Conti JB, Beaver TM.

J Interv Card Electrophysiol. 2012 Dec;35(3):351-3; discussion 353. doi: 10.1007/s10840-012-9718-x. Epub 2012 Sep 26.

Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease

Koppula S, Kumar H, More SV, Lim HW, Hong SM, Choi DK.

Molecules. 2012 Sep 26;17(10):11391-420. doi: 10.3390/molecules171011391.

Brain drug delivery systems for neurodegenerative disorders

Garbayo E, Ansorena E, Blanco-Prieto MJ.

Curr Pharm Biotechnol. 2012 Sep;13(12):2388-402. doi: 10.2174/138920112803341761.

A novel conceptual framework for balance training in Parkinson's disease-study protocol for a randomised controlled trial

Conradsson D, Löfgren N, Ståhle A, Hagströmer M, Franzén E.

BMC Neurol. 2012 Sep 27;12:111. doi: 10.1186/1471-2377-12-111.

Molecular mechanisms of cortical degeneration in Parkinson disease

Shulman JM, Schneider JA.

Neurology. 2012 Oct 23;79(17):1750-1. doi: 10.1212/WNL.0b013e31827040c6. Epub 2012 Sep 26.

The Magic Velvet Bean of Mucuna pruriens

Lampariello LR, Cortelazzo A, Guerranti R, Sticozzi C, Valacchi G.

J Tradit Complement Med. 2012 Oct;2(4):331-9. doi: 10.1016/s2225-4110(16)30119-5.

Genetics of Parkinson's disease - a clinical perspective

Cheon SM, Chan L, Chan DK, Kim JW.

J Mov Disord. 2012 Oct;5(2):33-41. doi: 10.14802/jmd.12009. Epub 2012 Oct 30.

Comorbidities of bladder pain syndrome/interstitial cystitis: a population-based study

Keller JJ, Chen YK, Lin HC.

BJU Int. 2012 Dec;110(11 Pt C):E903-9. doi: 10.1111/j.1464-410X.2012.11539.x. Epub 2012 Sep 28.

Systematic review on factors associated with medication non-adherence in Parkinson's disease

Daley DJ, Myint PK, Gray RJ, Deane KH.

Parkinsonism Relat Disord. 2012 Dec;18(10):1053-61. doi: 10.1016/j.parkreldis.2012.09.004. Epub 2012 Sep 28.

Poor insight into memory impairment in patients with Huntington disease

Sitek EJ, Sołtan W, Robowski P, Schinwelski M, Wieczorek D, Sławek J.

Neurol Neurochir Pol. 2012 Jul-Aug;46(4):318-25. doi: 10.5114/ninp.2012.30262.

Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG

Chiaravalloti A, Stefani A, Tavolozza M, Pierantozzi M, Di Biagio D, Olivola E, Di Pietro B, Stampanoni M, Danieli R, Simonetti G, Stanzione P, Schillaci O.

Mol Med Rep. 2012 Dec;6(6):1337-42. doi: 10.3892/mmr.2012.1104. Epub 2012 Sep 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias